These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8732467)

  • 21. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
    Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
    J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormone replacement therapy--women's expectations and fears].
    Schultz-Zehden B
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reality of menopausal hormone replacement therapy by French gynaecologists: OCEANIDES, a transversal and longitudinal national epidemiology study].
    Tamborini A
    Gynecol Obstet Fertil; 2003 Nov; 31(11):932-9. PubMed ID: 14623557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement and menopausal symptoms following hysterectomy.
    Langenberg P; Kjerulff KH; Stolley PD
    Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance considerations with hormone replacement therapy.
    Karakoç B; Erenus M
    Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy: why are general practitioners not prescribing more?
    Dunne FP; Sadler GJ; Crampton JA
    Int J Clin Pract; 1998; 52(5):285-8. PubMed ID: 9796557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of hormonal replacement therapy in general practice; a follow-up study.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1998 Jun; 29(2):125-31. PubMed ID: 9651901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
    Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
    Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study.
    Ena G; Rozenberg S
    Hum Reprod; 2003 Nov; 18(11):2245-8. PubMed ID: 14585867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scottish gynaecologists: their views on hormone replacement therapy.
    Campbell-Brown M; McEwan HP
    Health Bull (Edinb); 1992 May; 50(3):248-51. PubMed ID: 1506194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low use of long-term hormone replacement therapy in Denmark.
    Olesen C; Steffensen FH; Sørensen HT; Nielsen GL; Olsen J; Bergman U
    Br J Clin Pharmacol; 1999 Mar; 47(3):323-8. PubMed ID: 10215757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan.
    Nagata C; Matsushita Y; Shimizu H
    Maturitas; 1996 Nov; 25(3):201-7. PubMed ID: 8981337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The climacteric in The Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy.
    Barentsen R
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S7-11. PubMed ID: 8732466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.